packageValrubicin

valrubicin

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Valrubicin is an anticancer drug used to treat bladder cancer. It is an approved medicine, given as a topoisomerase inhibitor, though it is not authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q7912593 and the WHO ATC classification; not checked by a person.

name:valrubicin
ATC codes:L01DB09
DrugBank:DB00385
PubChem CID:454216
ChEBI:135876
Wikidata:Q7912593
formula:C34H36F3NO13
molar mass:723.65 g/mol (PubChem CID 454216)
logP:4 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown